InvestorsHub Logo
Followers 61
Posts 7855
Boards Moderated 0
Alias Born 12/07/2007

Re: None

Wednesday, 01/03/2018 12:54:31 PM

Wednesday, January 03, 2018 12:54:31 PM

Post# of 392
(iii) the Company changed its business model to focus on the operations and business of 0962. The Company will now be focusing on licensing, branding and marketing nutraceutical and wellness products, using nature and science to develop lasting contributions to health and well-being. The Company is currently marketing and selling its first product, CELLB9®, an immune system booster. This product is produced at the FDA approved facility of Samson Pharmaceuticals Inc. in the United States of America.